Publication Information

{'id': 'https://openalex.org/W2739875490', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-2620', 'title': 'Abstract 2620: Selecting the right chemotherapy partner for checkpoint inhibitors: an <i>in vivo</i> comparison of different drugs and dosages', 'display_name': 'Abstract 2620: Selecting the right chemotherapy partner for checkpoint inhibitors: an <i>in vivo</i> comparison of different drugs and dosages', 'publication_year': 2017, 'publication_date': '2017-07-01', 'ids': {'openalex': 'https://openalex.org/W2739875490', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-2620', 'mag': '2739875490'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-2620', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5017461647', 'display_name': 'Stefania Orecchioni', 'orcid': 'https://orcid.org/0000-0002-6781-7002'}, 'institutions': [{'id': 'https://openalex.org/I6141010', 'display_name': 'European Institute of Oncology', 'ror': 'https://ror.org/02vr0ne26', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126', 'https://openalex.org/I6141010']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Stefania Orecchioni', 'raw_affiliation_strings': ['European Inst. of Oncology, Milan, Italy.'], 'affiliations': [{'raw_affiliation_string': 'European Inst. of Oncology, Milan, Italy.', 'institution_ids': ['https://openalex.org/I6141010']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023850576', 'display_name': 'Giovanna Talarico', 'orcid': 'https://orcid.org/0000-0001-5051-6468'}, 'institutions': [{'id': 'https://openalex.org/I6141010', 'display_name': 'European Institute of Oncology', 'ror': 'https://ror.org/02vr0ne26', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126', 'https://openalex.org/I6141010']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Giovanna Talarico', 'raw_affiliation_strings': ['European Inst. of Oncology, Milan, Italy.'], 'affiliations': [{'raw_affiliation_string': 'European Inst. of Oncology, Milan, Italy.', 'institution_ids': ['https://openalex.org/I6141010']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022792518', 'display_name': 'Valentina Labanca', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I6141010', 'display_name': 'European Institute of Oncology', 'ror': 'https://ror.org/02vr0ne26', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126', 'https://openalex.org/I6141010']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Valentina Labanca', 'raw_affiliation_strings': ['European Inst. of Oncology, Milan, Italy.'], 'affiliations': [{'raw_affiliation_string': 'European Inst. of Oncology, Milan, Italy.', 'institution_ids': ['https://openalex.org/I6141010']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007502698', 'display_name': 'Patrizia Mancuso', 'orcid': 'https://orcid.org/0000-0003-3808-4257'}, 'institutions': [{'id': 'https://openalex.org/I6141010', 'display_name': 'European Institute of Oncology', 'ror': 'https://ror.org/02vr0ne26', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126', 'https://openalex.org/I6141010']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Patrizia Mancuso', 'raw_affiliation_strings': ['European Inst. of Oncology, Milan, Italy.'], 'affiliations': [{'raw_affiliation_string': 'European Inst. of Oncology, Milan, Italy.', 'institution_ids': ['https://openalex.org/I6141010']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5069836898', 'display_name': 'Francesco Bertolini', 'orcid': 'https://orcid.org/0000-0001-5660-3255'}, 'institutions': [{'id': 'https://openalex.org/I6141010', 'display_name': 'European Institute of Oncology', 'ror': 'https://ror.org/02vr0ne26', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126', 'https://openalex.org/I6141010']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Francesco Bertolini', 'raw_affiliation_strings': ['European Inst. of Oncology, Milan, Italy.'], 'affiliations': [{'raw_affiliation_string': 'European Inst. of Oncology, Milan, Italy.', 'institution_ids': ['https://openalex.org/I6141010']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.132, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.460252, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 63, 'max': 71}, 'biblio': {'volume': '77', 'issue': '13_Supplement', 'first_page': '2620', 'last_page': '2620'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12829', 'display_name': 'Advanced Breast Cancer Therapies', 'score': 0.9925, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11287', 'display_name': 'Cancer Genomics and Diagnostics', 'score': 0.9898, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cd11c', 'display_name': 'CD11c', 'score': 0.4469176}, {'id': 'https://openalex.org/keywords/chemoimmunotherapy', 'display_name': 'Chemoimmunotherapy', 'score': 0.4406331}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5563699}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5301168}, {'id': 'https://openalex.org/C167672396', 'wikidata': 'https://www.wikidata.org/wiki/Q417800', 'display_name': 'CD8', 'level': 3, 'score': 0.5147722}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.47936848}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.45465896}, {'id': 'https://openalex.org/C2779919695', 'wikidata': 'https://www.wikidata.org/wiki/Q4201963', 'display_name': 'CD11c', 'level': 4, 'score': 0.4469176}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.44087288}, {'id': 'https://openalex.org/C2780790343', 'wikidata': 'https://www.wikidata.org/wiki/Q5090610', 'display_name': 'Chemoimmunotherapy', 'level': 4, 'score': 0.4406331}, {'id': 'https://openalex.org/C79484868', 'wikidata': 'https://www.wikidata.org/wiki/Q5971673', 'display_name': 'IL-2 receptor', 'level': 4, 'score': 0.43145412}, {'id': 'https://openalex.org/C542903549', 'wikidata': 'https://www.wikidata.org/wiki/Q422248', 'display_name': 'Monoclonal antibody', 'level': 3, 'score': 0.42196906}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.42027265}, {'id': 'https://openalex.org/C2776090121', 'wikidata': 'https://www.wikidata.org/wiki/Q193529', 'display_name': 'T cell', 'level': 3, 'score': 0.41302577}, {'id': 'https://openalex.org/C2779282312', 'wikidata': 'https://www.wikidata.org/wiki/Q1956561', 'display_name': 'Myeloid', 'level': 2, 'score': 0.41053772}, {'id': 'https://openalex.org/C147483822', 'wikidata': 'https://www.wikidata.org/wiki/Q103537', 'display_name': 'Antigen', 'level': 2, 'score': 0.35793522}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.34729216}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3425477}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.32406765}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.24119449}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.20779908}, {'id': 'https://openalex.org/C127716648', 'wikidata': 'https://www.wikidata.org/wiki/Q104053', 'display_name': 'Phenotype', 'level': 3, 'score': 0.08626267}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-2620', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.82, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4389801181', 'https://openalex.org/W3046481156', 'https://openalex.org/W2990182272', 'https://openalex.org/W2736541443', 'https://openalex.org/W2467986011', 'https://openalex.org/W2284831226', 'https://openalex.org/W2144521864', 'https://openalex.org/W2047640573', 'https://openalex.org/W1633413575', 'https://openalex.org/W152518356'], 'abstract_inverted_index': {'Abstract': [0], 'Anti-PD-1': [1], 'and': [2, 23, 53, 56, 62, 85, 99, 124, 136, 156, 160, 184, 223, 227, 237, 240, 249, 263, 271, 275, 282, 295, 301, 306, 337, 347, 371, 375, 404, 411, 417, 449], 'anti-PD-L1': [3, 328], 'monoclonal': [4, 179], 'antibodies': [5, 180], '(checkpoint': [6], 'inhibitors,': [7], 'CIs)': [8], 'have': [9, 32, 67, 357], 'shown': [10], 'a': [11, 16, 37, 48, 128], 'remarkable': [12], 'clinical': [13, 30, 42, 199], 'activity': [14, 368], 'in': [15, 36, 100, 171, 292, 311, 365, 443], 'variety': [17, 129], 'of': [18, 20, 39, 75, 86, 111, 114, 130, 190, 198, 234, 241, 335, 369, 378, 446, 454], 'types': [19], 'solid': [21], 'cancers': [22], 'hematological': [24], 'malignancies.': [25], 'However,': [26], 'complete': [27], 'and/or': [28], 'long-lasting': [29], 'responses': [31], 'been': [33], 'observed': [34, 310], 'only': [35], 'minority': [38], 'patients.': [40], 'The': [41], 'response': [43], 'to': [44, 71, 382, 391, 397], 'CIs': [45], 'depends': [46], 'on': [47, 360], 'complex': [49], 'balance': [50, 396], 'between': [51], 'tumor-associated': [52], 'circulating': [54], 'CD3+CD4+': [55, 135], 'CD3+CD8+': [57, 137], 'T,': [58, 235, 269, 402], 'regulatory,': [59], 'B,': [60, 236], 'NK': [61, 238, 270, 405], 'myeloid/suppressor': [63], 'cell': [64, 132, 217, 362, 406], 'subsets.': [65], 'We': [66], 'used': [68], 'immunocompetent': [69], 'mice': [70, 102, 312], 'generate': [72], 'orthotopic': [73], 'models': [74, 98, 297], 'breast': [76], 'cancer': [77, 420], '(BC,': [78], 'injecting': [79, 90], '4T1': [80], 'triple': [81], 'negative': [82], 'murine': [83, 92, 174], 'cells)': [84], 'non-Hodgkin’s': [87], 'lymphoma': [88], '(NHL,': [89], 'A20': [91], 'malignant': [93], 'B': [94, 143, 281], 'cells).': [95], 'In': [96, 325], 'these': [97, 286], 'cancer-free': [101], 'we': [103, 193, 288], 'studied': [104], 'by': [105], '10-color': [106], 'flow': [107], 'cytometry': [108], 'the': [109, 232, 340, 366, 373, 376, 393, 435, 455], 'effect': [110], 'different': [112, 447], 'doses': [113, 265, 322, 334], '3': [115, 195, 214], 'widely-used,': [116], 'orally-active': [117], 'chemotherapy': [118, 191, 318, 355, 379, 437], 'drugs': [119, 166, 319, 356, 448], '(cyclophosphamide,': [120], 'CTX;': [121], 'capecitabine,': [122], '5FU;': [123], 'vinorelbine,': [125], 'VNR)': [126], 'over': [127], 'immune': [131, 361], 'subsets': [133, 218, 363], 'including': [134], 'T': [138], 'cells,': [139, 144], 'CD56+': [140], 'NKs,': [141], 'CD19+': [142], 'CD3+CD4+CD25++CD127low/neg': [145], 'Tregs,': [146, 280], 'GR1-CD11b+CD11c+': [147], 'monocytes,': [148], 'SSClowCD11b+GR1+': [149], 'total': [150], 'Myeloid-Derived': [151], 'Suppressor': [152], 'Cells': [153], '(t-MDSC,': [154], 'monocytic': [155], 'polymorphonuclear),': [157], 'SSChighCD11b+GR1+': [158, 283], 'granulocytes': [159], 'CD11c+CD11b-GR1-': [161], 'antigen-presenting': [162], 'cells': [163, 239], '(APCs).': [164], 'Chemotherapy': [165], 'were': [167, 211, 219, 309, 339], 'given': [168], 'alone': [169], 'or': [170, 176, 205, 316, 331], 'combination': [172], 'with': [173, 303, 314, 385], 'anti-PD-1': [175], 'anti': [177], 'PD-L1': [178], '(Bioxcell': [181], 'clones': [182], 'J43': [183], '10F.9G2,': [185], 'respectively).': [186], 'For': [187], 'every': [188], 'type': [189, 374], 'drugs,': [192], 'selected': [194], 'dosages': [196, 450], 'representative': [197], 'low-dose': [200], 'metronomic': [201], '(LDM),': [202], 'medium': [203], '(M),': [204], 'maximum': [206], 'tolerable': [207], '(MT)': [208], 'dosages.': [209], 'Mice': [210], 'treated': [212, 313], 'for': [213, 344, 439, 458], 'weeks,': [215], 'blood': [216], 'measured': [220], 'weekly.': [221], 'CTX': [222, 336], '5FU,': [224, 246, 251], 'at': [225, 260, 320], 'M': [226, 262, 274, 330], 'MT': [228, 264, 276, 321], 'dosages,': [229], 'reduced': [230, 247, 255, 279], 'significantly': [231], 'number': [233], 't-MDSC.': [242, 256, 272], 'CTX,': [243, 254, 299], 'but': [244, 252], 'not': [245, 253, 267], 'Tregs': [248, 410], 'APCs.': [250], 'At': [257, 273], 'variance,': [258], 'VNR': [259, 278, 302, 338], 'LDM,': [261], 'did': [266], 'reduce': [268, 409], 'doses,': [277], 'granulocytes.': [284], 'Considering': [285], 'data,': [287], 'designed': [289], 'preclinical': [290], 'protocols': [291], 'both': [293, 326], 'BC': [294], 'NHL': [296], 'associating': [298], '5FU': [300], 'CIs.': [304, 324, 386], 'Cumulative': [305], 'unbearable': [307], 'toxicities': [308], '2': [315], 'more': [317], 'plus': [323, 329], 'models,': [327], 'LDM': [332], 'combinatory': [333], 'most': [341], 'effective': [342], 'therapies': [343], 'reducing': [345], 'local': [346], 'metastatic': [348], 'neoplastic': [349], 'growth.': [350], 'Our': [351], 'data': [352], 'indicate': [353], 'that': [354, 372], 'relevant': [358], 'effects': [359], 'involved': [364], 'anti-neoplastic': [367], 'CIs,': [370], 'dosage': [377], 'are': [380, 389], 'crucial': [381], 'obtain': [383], 'synergy': [384], 'Further': [387], 'studies': [388], 'ongoing': [390], 'find': [392], 'right': [394, 436], 'chemotherapy/CI': [395], 'a)': [398], 'maintain': [399], 'an': [400, 442], 'adequate': [401], 'APC': [403], 'activity,': [407], 'b)': [408], 'myeloid': [412], 'suppressors,': [413], 'c)': [414], 'avoid': [415], 'toxicity,': [416], 'd)': [418], 'target': [419], 'cells.': [421], 'Citation': [422], 'Format:': [423], 'Stefania': [424], 'Orecchioni,': [425], 'Giovanna': [426], 'Talarico,': [427], 'Valentina': [428], 'Labanca,': [429], 'Patrizia': [430], 'Mancuso,': [431], 'Francesco': [432], 'Bertolini.': [433], 'Selecting': [434], 'partner': [438], 'checkpoint': [440], 'inhibitors:': [441], 'vivo': [444], 'comparison': [445], '[abstract].': [451], 'In:': [452], 'Proceedings': [453], 'American': [456], 'Association': [457], 'Cancer': [459, 472], 'Research': [460], 'Annual': [461], 'Meeting': [462], '2017;': [463], '2017': [464], 'Apr': [465], '1-5;': [466], 'Washington,': [467], 'DC.': [468], 'Philadelphia': [469], '(PA):': [470], 'AACR;': [471], 'Res': [473], '2017;77(13': [474], 'Suppl):Abstract': [475], 'nr': [476], '2620.': [477], 'doi:10.1158/1538-7445.AM2017-2620': [478]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2739875490', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-12-12T23:30:48.768076', 'created_date': '2017-08-08'}